CLNN · Clene Inc. · Metrics
$3.62
-0.23 (-5.97%)
At close · Sep 8
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern. To mitigate our funding needs, we plan to raise additional funding, including exploring equity financing and offerings, debt financing, licensing or collaboration arrangements with third parties, as well as utilizing our existing at-the-market facility and potential proceeds from the exercise of outstanding warrants and stock options. These plans are subject to market conditions and reliance on third parties, and there is no assurance that effective implementation of our plans will result in the necessary funding to continue current operations. During the three and six months ended June 30, 2026, we raised $7.0 million and $13.0 million, respectively, of gross proceeds from registered direct offerings of equity securities (see Note 13 to the condensed consolidated financial statements). While we have implemented cost-saving initiatives, including delaying and reducing certain research and development programs and commercialization efforts, reducing employee compensation, and eliminating certain staff positions, we have concluded that our plans do not alleviate the substantial doubt about our ability to continue as a going concern beyond one year from the date the condensed consolidated financial statements contained in this report are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$46.51M
Shares
12.85M
CLNN metrics
60 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$3.62
Market cap
$46.51M
Price action
20 metricsPrice change (1W)
-9.0%
Price change (30D)
-25.4%
Price change (3M)
-29.4%
Price change (6M)
-28.2%
Price change (YTD)
-34.4%
Price change (1Y)
-35.3%
Trailing year
Price change (5Y)
—
52-week high
$12.50
52-week low
$3.85
Change from 52-week high
-69.2%
Change from 52-week low
+0.0%
Annualized volatility
104.4%
Annualized volatility (3M)
60.1%
Beta
2.0
RSI (14D)
32.0
Price vs SMA 50
-25.2%
Price vs SMA 200
-33.5%
Avg volume (3M)
80,917
Relative volume
1.5
Average dollar volume
$420,014
Company
3 metricsSector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
12.85M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
251.1×
reciprocal yield 0.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-79.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
356.0×
reciprocal yield 0.3%
EV / revenue historical average (5Y)
332.8×
reciprocal yield 0.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2024-05-21
Profitability
9 metricsGross margin
70.1%
Operating margin
-10,432.0%
Trailing 12 months
Net margin
-20,059.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$20.55M
Net income (TTM)
−$39.52M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+233.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$197,000
Trailing 12 months
EPS growth YoY
-140.5%
Shares change YoY
-9.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-24.9%
Revenue CAGR (5Y)
-0.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-171.5%
Debt / equity
—
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.1
Interest coverage
-7.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.67M
Total assets
$23.04M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$15.91M
Capital expenditures (TTM)
$40,000
R&D (TTM)
$12.82M
SG&A (TTM)
—
Stock compensation (TTM)
$5.42M
R&D / revenue
6,505.6%
Stock compensation / revenue
2,751.3%
Ownership (13F)
3 metrics13F filers
33
13F filer change QoQ
+4
Institutional ownership
24.8%
Short interest
3 metricsShort interest
7.8%
Latest settlement · 9.6 days to cover
Days to cover
9.6d
Short-squeeze score
70 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1822791
CUSIP
185634201
13F (30d)
26 filings
26 filers
Visit website
Investor relations